From Corvelva, in Italy. Please note, this is a translation from the Italian.
Read the full analysis here.
In analyzing the Gardasil 9 papillomavirus vaccine, from a metagenomic and chemical point of view, we found many non-conformities that, to our opinion, they should require the authorities to re-analyze at least the lots analyzed by us, the immediate withdrawal if our data are confirmed and a wider re-evaluation of the analysis to be performed on all the vaccines on the market.
From what we could see the problems were, under the metagenomic profile, the presence of adventitious genetic material presents such as bacteria, human and mouse DNA, adventitious viruses like phages and retroviruses and yeasts.
What most impressed us was the presence of L1 fragments of the genome of papillomavirus. These fragments should not be present in the vaccine because the papillomavirus is carcinogenic and their presence together with the aluminum adjuvant is believed to be the cause of some of the serious adverse reactions in the injured.
The same chemical analysis, even if shocking due to the number of potential non-residual contaminants found, had left a huge question mark. The analysis with the technology used in the laboratories we identified, gave us 338 signals of which only 22% are known. What has seemed to many unbelievable, that is the list of the probably identified compounds, in reality, to us, it created enormous interest the remaining 78% not known.
A study of this unknown 78% started a further study and, after repeated analysis carried out in two different laboratories and with two different instruments, we can now tell you that a signal we found, compared to three databases consulted, leads us to determine that in some lots of Gardasil 9, especially in lot R009338, there is a contamination corresponding to an amazing drug called APDB. Read more here.